Immunization, measles second dose (% of children by the nationally) in Japan
Japan: Immunization, measles second dose (% of children by the nationally) was 96.0% in 2024. ▲ Rising
Immunization, measles second dose in Japan, 2008–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Japan is 96.0%, measured in 2024.
That represents a change of up 2.1% on the previous year and up 2.1% over ten years.
Over the whole period, immunization, measles second dose in Japan peaked at 97.0% in 2010 and was at its lowest, 78.0%, in 2008.
Japan ranks 25th of 178 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 17 years of available data.
Immunization, measles second dose (% of children by the nationally) in Japan, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2008 | 78.0% | — |
| 2009 | 92.0% | +17.9% |
| 2010 | 97.0% | +5.4% |
| 2011 | 92.0% | -5.2% |
| 2012 | 92.0% | +0.0% |
| 2013 | 93.0% | +1.1% |
| 2014 | 94.0% | +1.1% |
| 2015 | 93.0% | -1.1% |
| 2016 | 93.0% | +0.0% |
| 2017 | 95.0% | +2.2% |
| 2018 | 93.0% | -2.1% |
| 2019 | 93.0% | +0.0% |
| 2020 | 95.0% | +2.2% |
| 2021 | 94.0% | -1.1% |
| 2022 | 95.0% | +1.1% |
| 2023 | 94.0% | -1.1% |
| 2024 | 96.0% | +2.1% |
Japan compared with similar countries
- Japan's 96.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- Japan's 96.0% is above the median for East Asia & Pacific, which is 87.0%, 1.1× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 85.0% | 78.0% | 92.0% | 2 |
| 2010s | 93.5% | 92.0% | 97.0% | 10 |
| 2020s | 94.8% | 94.0% | 96.0% | 5 |
Countries ranked near Japan
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Un projection of annual infant deaths 178 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0163 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in Japan?
- Immunization, measles second dose in Japan was 96.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Japan?
- The highest recorded value was 97.0% in 2010.
- What is the lowest immunization, measles second dose recorded in Japan?
- The lowest recorded value was 78.0% in 2008.
- How does Japan rank for immunization, measles second dose?
- Japan ranks 25th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Japan?
- Over the last ten years it is up 2.1%. The long-run trend across the full record is rising.
- Where does this Japan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.